ASCIA News

  • Updated and new ASCIA HAE resources
    The ASCIA Hereditary Angioedema (HAE) Position Paper and Management Plan have been updated and are now available on the ASCIA website: www.allergy.org.au/hp/papers/hereditary-angioedema The urgent updating of these documents is due to Takhzyro® (lanadelumab) being PBS...
  • Updated ASCIA Adrenaline Injector Prescribing Guidelines and FAQ
    ASCIA Adrenaline (Epinephrine) Injector Prescribing Guidelines and Frequently Asked Questions (FAQ) have been updated, and are now available on the ASCIA website: Adrenaline Injectors FAQ Updated 12 January 2022 ASCIA Guidelines - Adrenaline (Epinephrine) Autoinjector...
  • COVID-19 vaccines are safe for people with allergies, including children
    From 10 January 2022 in Australia, and from 17 January 2022 in New Zealand, all children from five years of age are eligible for COVID-19 vaccination. The approval of mRNA COVID-19 vaccines in children aged from 5 to 16 years has been made following careful evaluation of...
  • Responding to an anaphylaxis emergency when there is limited access to an ambulance
    ASCIA is aware that there is limited access to ambulances in some regions, due to issues related to the latest COVID-19 outbreaks, and in rural or remote settings.  ASCIA's advice for people having anaphylaxis and their carers is as follows: Follow the ASCIA Action Plan for...
  • ASCIA's Plans for 2022
    As the end of another challenging year is approaching, we thank ASCIA members and supporters for your highly valued contributions throughout the past year. Despite the uncertainties during 2021, ASCIA has become an even stronger and more resilient organisation, with...
  • ASCIA Generic Action and First Aid Plans for Anaphylaxis now include QR codes
    With the widespread use of QR codes, and two brands of adrenaline (epinephrine) injector devices now available, a QR code has been added to the generic version of the red ASCIA Action Plan for Anaphylaxis and the generic version of the orange ASCIA First Aid Plan for...
  • ASCIA Food Allergy e-training
    ASCIA Food Allergy e-training for Health Professionals has been substantially updated and the new course is available from 30 November 2021. First developed in 2011, the latest version is for suitable for medical practitioners, nurses and dietitians. The following six...
  • New ASCIA Chronic Rhinosinusitis Position Paper
    Chronic Rhinosinusitis (CRS) is one of the most common chronic conditions worldwide, with a significant health-economic impact.  CRS is generally subclassified into two dominant subgroups: CRS with Nasal Polyps (CRSwNP), and RS sine (without) NP (CRSsNP). CRS with Nasal Polyps...
ASCIA Member Login

Site last updated: 14 Jan 2022
 

ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...

Join our mailing list here...

AIFA: Donate Now
AIFA: Donate Now
National Allergy Strategy
National Allergy Strategy
ASCIA: WAO Member
ASCIA: WAO Member
About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditiation

healthdirect

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.